1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015-2019 US Cancer Diagnostic Testing Market: Sales Forecasts By Market Segment and Supplier Shares by Test

This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Table of Contents

Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Industry Consolidation
  4. Managed Care
  5. Hospitals
  6. Admissions
  7. Length of Stay
  8. Industry Diversification
  9. Physician Demographics
10. Population Aging
      a. Chronic Illness
      b. Disease Incidence
      c. Susceptibility to Iatrogenesis
      d. Multiple Illness Cases
11. Laboratory Regulations

Market Structure
  1. Centralized Testing
      a. Hospitals
      b. Commercial/Private Laboratories
  2. Decentralized Testing
      a. Physician Offices/Group Practices
      b. Cancer Clinics
      c. Point-of-Care Testing
      d. Other Decentralized Testing Locations

Market Size, Growth, and Major Suppliers' Market Shares

List of Tables

Test Volume Forecasts by Market Segment
               
Sales Forecasts by Market Segment

AFP Testing: Market Shares of Major Suppliers

CA 15-3/27-29 Testing: Market Shares of Major Suppliers

CA 19-9 Testing: Market Shares of Major Suppliers

CEA Testing: Market Shares of Major Suppliers

PSA Testing: Market Shares of Major Suppliers

Contains 40 pages and 7 tables

This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Table Of Contents

2015-2019 US Cancer Diagnostic Testing Market: Sales Forecasts By Market Segment and Supplier Shares by Test
The US Cancer Diagnostic Testing Market:
Sales Forecasts by Market Segment and Supplier Shares by Test
Table of Contents
Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Cancer Clinics
c. Point of Care Testing
d. Other Decentralized Testing Locations
Market Size, Growth, and Major Suppliers' Market Shares
List of Table
Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
List of Table (Continued)
AFP Testing: Market Shares of Major Suppliers
CA 15-3/27-29 Testing: Market Shares of Major Suppliers
CA 19-9 Testing: Market Shares of Major Suppliers
CEA Testing: Market Shares of Major Suppliers
PSA Testing: Market Shares of Major Suppliers

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.